292 related articles for article (PubMed ID: 19384471)
1. PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.
Yang C; Plackett D; Needham D; Burt HM
Pharm Res; 2009 Jul; 26(7):1644-56. PubMed ID: 19384471
[TBL] [Abstract][Full Text] [Related]
2. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres.
Gilchrist SE; Rickard DL; Letchford K; Needham D; Burt HM
Mol Pharm; 2012 May; 9(5):1489-501. PubMed ID: 22482935
[TBL] [Abstract][Full Text] [Related]
3. Formulation Optimization and In Vitro Characterization of Granisetronloaded Polylactic-co-glycolic Acid Microspheres Prepared by a Dropping-in-liquid Emulsification Technique.
Ahmed AMQ; Chen LQ; Du HH; Sun W; Cao QR
Curr Drug Deliv; 2022; 19(6):721-729. PubMed ID: 34325634
[TBL] [Abstract][Full Text] [Related]
4. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
5. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
6. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
[TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique.
Lee S; Kim MS; Kim JS; Park HJ; Woo JS; Lee BC; Hwang SJ
J Microencapsul; 2006 Nov; 23(7):741-9. PubMed ID: 17123918
[TBL] [Abstract][Full Text] [Related]
9. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
Cevher E; Orhan Z; Sensoy D; Ahiskali R; Kan PL; Sağirli O; Mülazimoğlu L
J Microencapsul; 2007 Sep; 24(6):577-95. PubMed ID: 17654177
[TBL] [Abstract][Full Text] [Related]
10. Engineered PLGA microspheres for extended release of brexpiprazole:
Wu B; Wu L; He Y; Yin Z; Deng L
Drug Dev Ind Pharm; 2021 Jun; 47(6):1001-1010. PubMed ID: 34032181
[TBL] [Abstract][Full Text] [Related]
11. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
[TBL] [Abstract][Full Text] [Related]
12. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
13. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
14. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
15. In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres.
Li S; Shi X; Xu B; Wang J; Li P; Wang X; Lou J; Li Z; Yang C; Li S; Zhen P
J Biomater Appl; 2022 Apr; 36(9):1676-1688. PubMed ID: 35015589
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
17. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment.
Wang S; Downing G; Olsen KF; Sawyer TK; Cone RD; Schwendeman SP
J Control Release; 2023 Dec; 364():589-600. PubMed ID: 37678438
[TBL] [Abstract][Full Text] [Related]
18. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
[TBL] [Abstract][Full Text] [Related]
19. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
